Predictors of gastrostomy tube dependence in surgically managed oropharyngeal squamous cell carcinoma.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
02 2019
Historique:
accepted: 22 04 2018
pubmed: 9 9 2018
medline: 24 5 2019
entrez: 9 9 2018
Statut: ppublish

Résumé

To elucidate predictive factors in the perioperative period resulting in gastrostomy tube (G-tube) dependence for patients undergoing primary surgical treatment of oropharyngeal squamous cell carcinoma (OPSCC) in the modern era. Two hundred and thirty patients with known OPSCC treated with primary surgery were screened and selected from a retrospective database spanning from 2002 to 2012 at The Ohio State University Wexner Medical Center (Columbus, Ohio), with univariable and multivariable logistic regression modeling used to determine independent predictive factors resulting in G-tube dependence (defined as tube persistence/presence 1 year after surgery). Surgical approach, baseline characteristics, tumor (T)-nodal-metastasis stage, human papillomavirus status, extent of tissue resected, surgical complications, reconstructive technique, preoperative G-tube presence, and adjuvant treatment were recorded. Patients undergoing open surgery for OPSCC without adjuvant treatment had 42.9% G-tube dependence (44.6% with adjuvant chemoradiation [CRT]) compared to 0% for those undergoing transoral nonrobotic surgery (8.1% with adjuvant CRT) and 0% for those undergoing transoral robotic surgery (10.3% with adjuvant CRT). In multivariable analysis, greater than 25% of the oral tongue resected (odds ratio [OR] 12.29; P = 0.03), an open surgical approach (OR 5.72; P < 0.01) and T3/T4 tumor stage (OR 2.84; P = 0.02) were independent and significant predictors of G-tube dependence. Surgical approach, advanced tumor stage, and oral tongue resection may influence the development of nutritional dependence for surgically treated patients with OPSCC. 4 Laryngoscope, 129:415-421, 2019.

Identifiants

pubmed: 30194767
doi: 10.1002/lary.27290
pmc: PMC9017431
mid: NIHMS1787154
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-421

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002733
Pays : United States

Informations de copyright

© 2018 The American Laryngological, Rhinological and Otological Society, Inc.

Références

JAMA Otolaryngol Head Neck Surg. 2013 Nov;139(11):1099-108
pubmed: 23576186
J Med Imaging Radiat Oncol. 2009 Oct;53(5):494-9
pubmed: 19788486
Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1205-9
pubmed: 8985044
Int J Cancer. 2008 Jun 15;122(12):2656-64
pubmed: 18360824
J Natl Cancer Inst. 2008 Mar 19;100(6):407-20
pubmed: 18334711
Head Neck. 2011 Dec;33(12):1683-94
pubmed: 21284056
Oral Oncol. 2014 Aug;50(8):696-703
pubmed: 24917389
Arch Otolaryngol Head Neck Surg. 2011 Nov;137(11):1112-6
pubmed: 22106235
Cancer. 2016 May 15;122(10):1523-32
pubmed: 26970050
Mayo Clin Proc. 2012 Mar;87(3):219-25
pubmed: 22386176
Otolaryngol Head Neck Surg. 2014 Jun;150(6):968-75
pubmed: 24618503
Recent Results Cancer Res. 1991;121:269-82
pubmed: 1907019
Recent Results Cancer Res. 2017;206:251-256
pubmed: 27699545
Head Neck. 2016 Apr;38 Suppl 1:E1794-802
pubmed: 26694981
Nutr Cancer. 2005;52(1):29-34
pubmed: 16091001
Arch Otolaryngol Head Neck Surg. 2004 Apr;130(4):401-8
pubmed: 15096421
Otolaryngol Head Neck Surg. 2001 Dec;125(6):645-8
pubmed: 11743469
Laryngoscope. 2015 Jul;125(7):1637-43
pubmed: 25781307
Eur Arch Otorhinolaryngol. 2013 Mar;270(3):1075-83
pubmed: 22763429
N Engl J Med. 1991 Jun 13;324(24):1685-90
pubmed: 2034244
Laryngoscope. 2014 Jan;124(1):131-8
pubmed: 23832649
Cancer. 2002 Jun 1;94(11):2967-80
pubmed: 12115386
Head Neck. 2011 Apr;33(4):490-6
pubmed: 20824806
Ann Surg Oncol. 2015 Dec;22(13):4422-31
pubmed: 25893414
Oncology (Williston Park). 2000 Nov;14(11A):163-94
pubmed: 11195409
Semin Radiat Oncol. 1992 Jul;2(3):142-148
pubmed: 10717029
J Clin Gastroenterol. 2001 Sep;33(3):215-7
pubmed: 11500610
Cancer. 2007 Oct 1;110(7):1429-35
pubmed: 17724670
Laryngoscope. 1992 Sep;102(9):977-80
pubmed: 1518361
Laryngoscope. 2003 Aug;113(8):1294-8
pubmed: 12897548
J Clin Oncol. 2013 Dec 20;31(36):4550-9
pubmed: 24248688

Auteurs

Vivek R Varma (VR)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Antoine Eskander (A)

Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada.

Stephen Y Kang (SY)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Bhavna Kumar (B)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Nicole V Brown (NV)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Songzhu Zhao (S)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Guy Brock (G)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Amit Agrawal (A)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Ricardo L Carrau (RL)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Matthew O Old (MO)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Enver Ozer (E)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

James W Rocco (JW)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

David E Schuller (DE)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Peter T Dziegielewski (PT)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Michael J Cipolla (MJ)

Department of Otolaryngology-Head and Neck Surgery, The James Cancer Hospital and Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, U.S.A.

Theodoros N Teknos (TN)

UH Cleveland Medical Center- Department of Otolaryngology, Head and Neck Surgery, Cleveland, Ohio, U.S.A.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH